Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

pDONR223-ZAP70 Citations (2)

Originally described in: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.
Johannessen CM, Boehm JS, Kim SY, Thomas SR, Wardwell L, Johnson LA, Emery CM, Stransky N, Cogdill AP, Barretina J, Caponigro G, Hieronymus H, Murray RR, Salehi-Ashtiani K, Hill DE, Vidal M, Zhao JJ, Yang X, Alkan O, Kim S, Harris JL, Wilson CJ, Myer VE, Finan PM, Root DE, Roberts TM, Golub T, Flaherty KT, Dummer R, Weber BL, Sellers WR, Schlegel R, Wargo JA, Hahn WC, Garraway LA Nature. 2010 Nov 24. ():.
PubMed Journal

Articles Citing pDONR223-ZAP70

Articles
CCR7 Is Recruited to the Immunological Synapse, Acts as Co-stimulatory Molecule and Drives LFA-1 Clustering for Efficient T Cell Adhesion Through ZAP70. Laufer JM, Kindinger I, Artinger M, Pauli A, Legler DF. Front Immunol. 2019 Jan 14;9:3115. doi: 10.3389/fimmu.2018.03115. eCollection 2018. PubMed
The Pellino1-PKCtheta Signaling Axis Is an Essential Target for Improving Antitumor CD8+ T-lymphocyte Function. Park J, Lee SY, Jeon Y, Kim KM, Lee JK, Ko J, Park EJ, Yoon JS, Kang BE, Ryu D, Lee H, Shin SJ, Go H, Lee CW. Cancer Immunol Res. 2022 Mar 1;10(3):327-342. doi: 10.1158/2326-6066.CIR-21-0419. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.